Last --
Change Today 0.00 / 0.00%
Volume 0.0
524669 On Other Exchanges
Symbol
Exchange
524669 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

hester biosciences ltd (524669) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HESTER BIOSCIENCES LTD (524669)

Related News

No related news articles were found.

hester biosciences ltd (524669) Related Businessweek News

No Related Businessweek News Found

hester biosciences ltd (524669) Details

Hester Biosciences Limited manufactures and markets animal vaccines and health products in India and internationally. It produces live vaccines for avians, swine, and large animals; inactivated vaccines for avians; and health products for avians and large animals. The company also offers seroprofiling services to producers for evaluating the immune response to administered vaccines and/or to obtain evidence of flock exposure to field strains; sero-monitoring for poultry farms; and mastitis prevention programs for the cattle farms. In addition, it manufactures feed additives and veterinary diagnostics products; and trades in poultry vaccines and large animal health products. Hester Biosciences Limited was founded in 1987 and is based in Ahmedabad, India.

250 Employees
Last Reported Date: 08/11/11
Founded in 1987

hester biosciences ltd (524669) Top Compensated Officers

Managing Director, Chief Executive Officer an...
Total Annual Compensation: 4.0M
Compensation as of Fiscal Year 2013.

hester biosciences ltd (524669) Key Developments

Hester Biosciences Ltd Announces Board Changes

Hester Biosciences Ltd. announced that the Board of Directors of the company at its meeting held on July 24, 2014, has resigned Mr. Darayus Lakdawalla from the Board and Ms. Grishma Nanavaty has been appointed as an Independent Director of the Company. The Board has reconstituted various Committees due to above change in Board Members.

Hester Biosciences Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Hester Biosciences Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales/income from operations of INR 233.04 million compared to INR 160.44 million a year ago. Profit from operations before other income, finance cost and exceptional items was INR 64.57 million compared to INR 45.25 million a year ago. Profit from ordinary activities before tax was INR 55.05 million compared to INR 36.31 million a year ago. Net profit for the period was INR 43.43 million or INR 5.11 per basic and diluted share compared to INR 19.82 million or INR 2.33 per basic and diluted share a year ago.

Hester Biosciences Ltd, Board Meeting, Jul 24, 2014

Hester Biosciences Ltd, Board Meeting, Jul 24, 2014. Agenda: To consider unaudited standalone earnings results for the first quarter ended June 30, 2014; and to consider Board changes.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HBIO:IN 324.70 INR +15.45

524669 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 524669.
View Industry Companies
 

Industry Analysis

524669

Industry Average

Valuation 524669 Industry Range
Price/Earnings 21.2x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 13.3x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HESTER BIOSCIENCES LTD, please visit www.hesterpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.